BENIGN PROSTATIC HYPERPLASIA AND ITS NOVEL TREATMENT STRATEGIES: A REVIEW

Reshma PM
Department of Pharmacy Practice, The Dale View College of Pharmacy and Research Centre, Punalal P.O, Poovachal, Trivandrum-695575, Kerala, India.
Anjana Sankar AJ
Department of Pharmacy Practice, The Dale View College of Pharmacy and Research Centre, Punalal P.O, Poovachal, Trivandrum-695575, Kerala, India.
Arya M, Fabina F
Department of Pharmacy Practice, The Dale View College of Pharmacy and Research Centre, Punalal P.O, Poovachal, Trivandrum-695575, Kerala, India.
Shijin VS
Department of Pharmacy Practice, The Dale View College of Pharmacy and Research Centre, Punalal P.O, Poovachal, Trivandrum-695575, Kerala, India.
Sini SG
Department of Pharmacy Practice, The Dale View College of Pharmacy and Research Centre, Punalal P.O, Poovachal, Trivandrum-695575, Kerala, India.
Dawn VJ
Department of Pharmacy Practice, The Dale View College of Pharmacy and Research Centre, Punalal P.O, Poovachal, Trivandrum-695575, Kerala, India.

Benign prostatic hyperplasia ,urolift device , tissue remodelling ,prostatic artery embolisation ,

Benign Prostatic Hyperplasia (BPH) is a common urological condition which is due to the enlargement of prostate gland and potentially slowing or blocking the urine stream. It mainly affects the quality of life of the patient. Etiological factors include age, environmental factors, oxidative stress, tissue remodelling, inflammation, metabolic symptoms and hormonal factors. Lower Urinary Tract Symptoms include hesitancy, intermittency, straining, and dubbling and decreased caliber of urine stream. Nowadays, novel treatment strategies are also emerging along with conventional treatment options

9 , 2 , 2019